Selling And Administration Expenses Endring Dato
Ardelyx USD 76.07M 11.1M 2024-12
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Cipla INR 11.98B 102.6M 2024-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.37M 361K 2024-12
CSL USD 1.38B 341M 2024-06
Galapagos EUR 43.8M 2.55M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Grifols EUR 269.48M 49.95M 2024-12
Life Technologies USD 3.59M 256K 2024-12
Novartis USD 3.5B 368M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
United Therapeutics USD 170.1M 7.6M 2025-03



Life Technologies Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.